130 related articles for article (PubMed ID: 19041715)
21. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
[TBL] [Abstract][Full Text] [Related]
22. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.
Jons C; Moss AJ; Lopes CM; McNitt S; Zareba W; Goldenberg I; Qi M; Wilde AA; Shimizu W; Kanters JK; Towbin JA; Ackerman MJ; Robinson JL
J Cardiovasc Electrophysiol; 2009 Aug; 20(8):859-65. PubMed ID: 19490272
[TBL] [Abstract][Full Text] [Related]
23. Isoproterenol exacerbates a long QT phenotype in Kcnq1-deficient neonatal mice: possible roles for human-like Kcnq1 isoform 1 and slow delayed rectifier K+ current.
Knollmann BC; Casimiro MC; Katchman AN; Sirenko SG; Schober T; Rong Q; Pfeifer K; Ebert SN
J Pharmacol Exp Ther; 2004 Jul; 310(1):311-8. PubMed ID: 15004216
[TBL] [Abstract][Full Text] [Related]
24. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
Aromolaran AS; Subramanyam P; Chang DD; Kobertz WR; Colecraft HM
Cardiovasc Res; 2014 Dec; 104(3):501-11. PubMed ID: 25344363
[TBL] [Abstract][Full Text] [Related]
25. Truncated KCNQ1 mutant, A178fs/105, forms hetero-multimer channel with wild-type causing a dominant-negative suppression due to trafficking defect.
Aizawa Y; Ueda K; Wu LM; Inagaki N; Hayashi T; Takahashi M; Ohta M; Kawano S; Hirano Y; Yasunami M; Aizawa Y; Kimura A; Hiraoka M
FEBS Lett; 2004 Sep; 574(1-3):145-50. PubMed ID: 15358555
[TBL] [Abstract][Full Text] [Related]
26. Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1.
Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
Gene; 2012 Dec; 511(1):26-33. PubMed ID: 23000022
[TBL] [Abstract][Full Text] [Related]
27. Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.
Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
Biochim Biophys Acta; 2011 Apr; 1812(4):488-94. PubMed ID: 21241800
[TBL] [Abstract][Full Text] [Related]
28. Basolateral localisation of KCNQ1 potassium channels in MDCK cells: molecular identification of an N-terminal targeting motif.
Jespersen T; Rasmussen HB; Grunnet M; Jensen HS; Angelo K; Dupuis DS; Vogel LK; Jorgensen NK; Klaerke DA; Olesen SP
J Cell Sci; 2004 Sep; 117(Pt 19):4517-26. PubMed ID: 15316073
[TBL] [Abstract][Full Text] [Related]
29. A di-acidic sequence motif enhances the surface expression of the potassium channel TASK-3.
Zuzarte M; Rinné S; Schlichthörl G; Schubert A; Daut J; Preisig-Müller R
Traffic; 2007 Aug; 8(8):1093-100. PubMed ID: 17547699
[TBL] [Abstract][Full Text] [Related]
30. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification.
Crotti L; Spazzolini C; Schwartz PJ; Shimizu W; Denjoy I; Schulze-Bahr E; Zaklyazminskaya EV; Swan H; Ackerman MJ; Moss AJ; Wilde AA; Horie M; Brink PA; Insolia R; De Ferrari GM; Crimi G
Circulation; 2007 Nov; 116(21):2366-75. PubMed ID: 17984373
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional changes in a synthetic S5 segment of KvLQT1 channel as a result of a conserved amino acid substitution that occurs in LQT1 syndrome of human.
Verma R; Ghosh JK
Biochim Biophys Acta; 2010 Mar; 1798(3):461-70. PubMed ID: 20044973
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of channel function after alteration of amino acid residues at the pore center of KCNQ1 channel.
Ikrar T; Hanawa H; Watanabe H; Aizawa Y; Ramadan MM; Chinushi M; Horie M; Aizawa Y
Biochem Biophys Res Commun; 2009 Jan; 378(3):589-94. PubMed ID: 19056345
[TBL] [Abstract][Full Text] [Related]
33. Long QT syndrome-associated mutations in the voltage sensor of I(Ks) channels.
Henrion U; Strutz-Seebohm N; Duszenko M; Lang F; Seebohm G
Cell Physiol Biochem; 2009; 24(1-2):11-6. PubMed ID: 19590188
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a novel mutant KCNQ1 channel subunit lacking a large part of the C-terminal domain.
Kimoto K; Kinoshita K; Yokoyama T; Hata Y; Komatsu T; Tsushima E; Nishide K; Yamaguchi Y; Mizumaki K; Tabata T; Inoue H; Nishida N; Fukurotani K
Biochem Biophys Res Commun; 2013 Oct; 440(2):283-8. PubMed ID: 24070608
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population.
Brink PA; Crotti L; Corfield V; Goosen A; Durrheim G; Hedley P; Heradien M; Geldenhuys G; Vanoli E; Bacchini S; Spazzolini C; Lundquist AL; Roden DM; George AL; Schwartz PJ
Circulation; 2005 Oct; 112(17):2602-10. PubMed ID: 16246960
[TBL] [Abstract][Full Text] [Related]
36. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome.
Shalaby FY; Levesque PC; Yang WP; Little WA; Conder ML; Jenkins-West T; Blanar MA
Circulation; 1997 Sep; 96(6):1733-6. PubMed ID: 9323054
[TBL] [Abstract][Full Text] [Related]
37. Microscopic mechanisms for long QT syndrome type 1 revealed by single-channel analysis of I(Ks) with S3 domain mutations in KCNQ1.
Eldstrom J; Wang Z; Werry D; Wong N; Fedida D
Heart Rhythm; 2015 Feb; 12(2):386-94. PubMed ID: 25444851
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis of the delayed rectifier current I(ks)in heart.
Kurokawa J; Abriel H; Kass RS
J Mol Cell Cardiol; 2001 May; 33(5):873-82. PubMed ID: 11343411
[TBL] [Abstract][Full Text] [Related]
39. [KCNQ 1 (KvLQT1) missense mutation causing congenital long QT syndrome (Jervell-Lange-Nielsen) in a Mexican family].
Márquez MF; Ramos-Kuri M; Hernández-Pacheco G; Estrada J; Fabregat JR; Pérez-Vielma N; Gómez-Flores J; González-Hermosillo A; Cárdenas M; Vargas-Alarcón G
Arch Cardiol Mex; 2006; 76(3):257-62. PubMed ID: 17091796
[TBL] [Abstract][Full Text] [Related]
40. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome.
Schwartz PJ; Vanoli E; Crotti L; Spazzolini C; Ferrandi C; Goosen A; Hedley P; Heradien M; Bacchini S; Turco A; La Rovere MT; Bartoli A; George AL; Brink PA
J Am Coll Cardiol; 2008 Mar; 51(9):920-9. PubMed ID: 18308161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
